Literature DB >> 18235954

Evaluation of incapacity level in leprosy: a strategy to sensitize and train the nursing team.

Reinaldo Antonio da Silva Sobrinho1, Thais Aidar de Freitas Mathias, Eunice Alves Gomes, Patrícia Barbosa Lincoln.   

Abstract

The main problems caused by leprosy are physical incapacities. This study evaluated the level of patients' incapacity in treatment and in discharge in 11 municipal districts of the 14th Regional of Health of Paraná, at the same time it promoted discussion and qualified nursing professionals of local teams. It was verified that 79.8% of the population evaluated presented some degree of incapacity and that some of the professionals ignored the evaluation technique. The percentage of patients with incapacity levels I and II was high, fact that corroborates the late diagnosis of cases. The need of a permanent self-care process associated to polichemotherapy and continuous evaluation of new and old cases in order to avoid the illness physical incapacities is highlighted.

Entities:  

Mesh:

Year:  2007        PMID: 18235954     DOI: 10.1590/s0104-11692007000600011

Source DB:  PubMed          Journal:  Rev Lat Am Enfermagem        ISSN: 0104-1169


  2 in total

1.  Patients' perceptions on the performance of a local health system to eliminate leprosy,Paraná State, Brazil.

Authors:  Flávia Meneguetti Pieri; Michelle Mosna Touso; Ludmila Barbosa Bandeira Rodrigues; Mellina Yamamura; Ione Carvalho Pinto; Elma Mathias Dessunti; Juliane de Almeida Crispim; Antônio Carlos Vieira Ramos; Luiz Henrique Arroyo; Marcelino Santos Neto; Maria Concebida da Cunha Garcia; Marcela Paschoal Popolin; Tatiane Ramos dos Santos Silveira; Ricardo Alexandre Arcêncio
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

2.  Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study.

Authors:  Xiaohua Chen; Hong-Bing Liu; Tie-Jun Shui; Shun Zha
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.